HDFC Pharma and Healthcare Fund Direct Growth NFO

HDFC Pharma and Healthcare Fund Direct Growth NFO

Compare
Equity
Direct
Sector - Healthcare

NAV: ₹ 10 as on 28-09-2023

About the Fund

HDFC Pharma and Healthcare Fund Direct Growth is an equity new fund offer (NFO) launched by HDFC Asset Management Co Ltd. The investors can apply to the NFO from 14 September 2023 to 28 September 2023. As per the SEBI defined riskometer, the HDFC Pharma and Healthcare Fund Direct Growth is rated Very High Risk.

HDFC Pharma and Healthcare Fund Direct Growth has defined its benchmark as Nifty 500.

HDFC Pharma and Healthcare Fund Direct Growth Overview

NAV Price
NAV Price
₹ 10
Launch Date
Launch Date
14 September 2023
End Date
End Date
28 September 2023
Allotment Date
Allotment Date
05 October 2023
Exit Load
Exit Load
1%
Benchmark
Benchmark
S&P BSE Healthcare TR INR

Frequently Asked Questions

HDFC Pharma and Healthcare Fund Direct Growth NFO (new fund offer) start date: 2023-09-14.
HDFC Pharma and Healthcare Fund Direct Growth NFO (new fund offer) close date: 2023-09-28.
HDFC Pharma and Healthcare Fund Direct Growth NFO (new fund offer) NAV: Rs. ₹10.
is the Fund Manager of HDFC Pharma and Healthcare Fund Direct Growth as per NFO filings?
HDFC Pharma and Healthcare Fund Direct Growth NFO (new fund offer) allotment date: 2023-10-05